We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





AI Takes Guesswork Out Of Lateral Flow Testing

By LabMedica International staff writers
Posted on 19 Oct 2022
Print article
Image: Researchers show that machine learning-based apps could be beneficial for diagnostic testing at home (Photo courtesy of Pexels)
Image: Researchers show that machine learning-based apps could be beneficial for diagnostic testing at home (Photo courtesy of Pexels)

An artificial intelligence (AI) app to read COVID-19 lateral flow tests helped to reduce false results in a new trial.

A team of researchers from the University of Birmingham (Birmingham, UK), Durham University (Durham, UK) and Oxford University (Oxford, UK) tested whether a machine learning algorithm could improve the accuracy of results from antigen lateral flow devices for COVID-19. The LFD AI Consortium team worked at UK Health Security Agency assisted test centres and with health care workers conducting self-testing to trial the AI app. More than 100,000 images were submitted as part of the study, and the team found that the algorithm was able to increase the sensitivity of results, determining between a true positive and false negative, from 92% to 97.6% accuracy.

“The widespread use of antigen lateral flow devices was a significant moment not just during the pandemic, but has also introduced diagnostic testing to many more people in society. One of the drawbacks with LFD testing for COVID, pregnancy and any other future use is the ‘faint line’ question – where we can’t quite tell if it’s a positive or not,” said Professor Andrew Beggs, Professor of Cancer Genetics & Surgery at the University of Birmingham and lead author of the study. “The study looked at the feasibility of using machine learning to take the guesswork out of the faint line tests, and we’re pleased to see that the app saw an increase in sensitivity of the tests, reducing the numbers of false negatives. The promise of this type of technology could be used in lots of applications, both to reduce uncertainty about test results and provide a crucial support for visually impaired people.”

“The increase in sensitivity and overall accuracy is significant and it shows the potential of this app by reducing the number of false negatives and future infections. Crucially, the method can also be easily adapted to the evaluation of other digital readers for lateral flow type devices,” added Professor Camila Caiado, Professor of Statistics at Durham University and chief statistician on the project.

Related Links:
University of Birmingham
Durham University
Oxford University

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
COVID-19 TEST READER
COVID-19-CHECK-1 EASY READER+
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Pathology

view channel
Image: Microscopic images showing healthy villi on the left and diseased villi on the right (Photo courtesy of Florian Jaeckle/University of Cambridge)

Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy

Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.